TrialPath
← Back to searchRecruiting

Motor Network Physiology

NCT04957095 · University of Texas Southwestern Medical Center
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
Motor Network Physiology Characterization During Deep Brain Stimulation Surgery
About this study
The brain networks controlling movement are complex, involving multiple areas of the brain. Some neurological disorders, like Parkinson's disease (PD) and essential tremor (ET), cause abnormalities in these brain networks. Deep brain stimulation is a treatment that is used to treat these types of neurological diseases and is thought to help patients by modulating brain networks responsible for movement. Levodopa medication is also used to modulate this brain networks in patients with PD. The overall objective is to develop a unified theory of basal ganglia thalamocortical (BGTC) circuit dynamics that accounts for disease symptomatology, movement, and their inter-relationship. The underlying hypothesis, is that the rigidity and bradykinesia of PD are fundamentally related to excessive functional coupling across nodes in the BGTC motor circuit impeding effective information flow. In this research, the investigator will take advantage of the unique opportunity provided by awake deep brain stimulation surgery to learn more about how the brain functions in a diseased state and how deep brain stimulation changes these networks to make movement more normal. The investigator will simultaneously assess cortical and subcortical electrophysiology in relation to clinical symptoms and behavioral measures and in response to deep brain stimulation, cortical stimulation, and pharmacologic therapy in patients undergoing Deep Brain Stimulation (DBS) implantation surgery.
Eligibility criteria
Inclusion Criteria: * Diagnosis of Parkinson's disease who have been recommended to undergo deep brain stimulation for management of their movement disorder * Preoperative MRI without evidence of cortical or subdural adhesions or vascular abnormalities * Willingness and ability to cooperate during conscious operative procedure for up to 40 minutes Exclusion Criteria: * Patients with recent use (within one week) of anticoagulant or antiplatelet agents * Neurocognitive testing indicating amnestic cognitive deficits
Study design
Enrollment target: 120 participants
Allocation: na
Masking: none
Age groups: adult, older_adult
Timeline
Starts: 2022-02-18
Estimated completion: 2028-12-01
Last updated: 2025-08-14
Interventions
Drug: Apomorphine Injectable SolutionOther: Subcortical Stimulation
Primary outcomes
  • cortical ECoG and subcortical recordings (baseline)
  • Behavioral assessment (baseline)
Sponsor
University of Texas Southwestern Medical Center · other
With: University of California, Los Angeles, National Institute of Neurological Disorders and Stroke (NINDS)
Contacts & investigators
ContactNader Pouratian, MD, PhD · contact · nader.pouratian@utsouthwestern.edu · (214)645-5465
ContactSachil Chilukuri · contact · sahil.chilukuri@utsouthwestern.edu · 2146455465
InvestigatorNader Pouratian, MD, PhD · principal_investigator, University of Texas Southwestern Medical Center
All locations (1)
UT Southwestern Medical CenterRecruiting
Dallas, Texas, United States
Motor Network Physiology · TrialPath